FlandersBio

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "FlandersBio" – news · newspapers · books · scholar · JSTOR (March 2015) (Learn how and when to remove this message) The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources: "FlandersBio" – news · newspapers · books · scholar · JSTOR (March 2015) (Learn how and when to remove this message) (Learn how and when to remove this message)

flanders.bio, founded in 2004, is the networking organisation for the life sciences sector in Flanders and represents and supports around 350 member companies. The key strategic objectives of flanders.bio are knowledge exchange and valorisation, human capital development, internationalization of the cluster activities and visibility, familiarization of the public with products derived from the sector and the further development of a supportive environment for the members of flanders.bio.

The flanders.bio network brings together companies with activities in the life sciences – companies that are for example developing biopharmaceuticals, medical technologies or agricultural or industrial biotech products. The network also welcomes research institutes, universities and providers of capital, services and technologies to the life sciences community.^{[citation needed]}

Wouter Piepers is the CEO of flanders.bio. Following his appointment in early 2022, Willem Dhooge, previously co-General Manager (with Pascal Engelen), was appointed COO.[1]

Dirk Reyn (Managing Partner Bioqube Factory Fund) is Chairman of the flanders.bio Board of Directors, with Erwin Blomsma (CEO and co-founder at ViroVet) is Vice-Chairman.[2]